Regarding comorbidities in the exposed group, most patients did not have diabetes(81.5%), and all of them underwent some type of treatment; in the non-exposed group,most had diabetes (60.3%), and most of those who had the disease were under sometreatment (50.8%) (Supplementary material).The most cited treatments were: NPH insulin, glibenclamide, metformin, empaglifozin,linagliptin and glyciphage. Here, INS is linked to diabetes mellitus.